We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Rapid Malaria Test Assessed for Field Use

By LabMedica International staff writers
Posted on 13 Dec 2012
Rapid diagnostic tests (RDT) for malaria infections could replace light microscopy in poor resource locations as their ease of use and accuracy are improved. More...


Although light microscopy (LM) is the gold standard for malaria diagnosis it is not available in many outlying health facilities and is time consuming, requires highly trained personnel and needs careful preparation and application of reagents to ensure quality results.

Scientists at the University of Gondar (Ethiopia) collected blood samples from 254 patients suspected to have malaria at a health center in Northwestern Ethiopia in the late malaria transmission-peak season from November 2011 to December 2011. The male to female ratio was 1.57:1, while the mean age of the participants was 21.4 years with an age range of 5 months to 75 years. Most of the participants were from rural areas of the district. The samples were examined immediately by light microscopy (LM) and the RDT.

The overall parasite positivity using LM was 104 (40.9%): 40 (15.7%) for Plasmodium falciparum, 58 (22.8%) for P. vivax and six (2.4%) had mixed infections. The CareStart RDT gave an overall parasite positivity of 100 (39.4%) with 50 (19.7%) for P. falciparum, 24 (9.5%) for P. vivax and 26 (10.2%) for mixed infections. Difference in detection of P. falciparum parasites using either the LM or the RDT was insignificant, but difference in detection of P. vivax using the LM and RDT was found to be significant.

The CareStart Malaria COMBO Test kit (Diasys Ltd.; New York, NY, USA) is a three-band RDT detecting histidine-rich protein 2 (HRP-2) and PAN- lactate dehydrogenase (pLDH) and results are obtained in 20 minutes. The test has an overall sensitivity of 95% and specificity of 94.2%. The sensitivity and specificity for mixed infections and non-falciparum malaria was slightly less. The authors concluded that the CareStart RDT test showed good sensitivity and specificity with an excellent agreement to the reference light microscopy. The RDT could therefore be used in place of microscopy, which in poor set-ups cannot be used routinely. The full study is available since in November 2012 in the Malaria Journal.

Related Links:
University of Gondar
Diasys Ltd.



Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Rheumatoid Factors (RF) Test
Rheumatoid Factors (RF)
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.